A critical review on HE4 performance in endometrial cancer: where are we now?

Author： Angioli Roberto   Miranda Andrea   Aloisi Alessia   Montera Roberto   Capriglione Stella   Cicco Nardone Carlo   Terranova Corrado   Plotti Francesco  

Publisher： Springer Publishing Company

ISSN： 1010-4283

Source： Tumor Biology, Vol.35, Iss.2, 2014-02, pp. : 881-887

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Therapeutic Targets in Triple Negative Breast Cancer - Where are we now?

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 6, Iss. 2, 2011-05 ,pp. : 196-209

Bentham Science Publishers

Access to resources Recommend Favorite

Small-cell lung cancer: where are we now and what can we expect for the future?

By Karachaliou Niki   Rosell Rafael  

Future Oncology, Vol. 9, Iss. 8, 2013-08 ,pp. : 1065-1068

Future Medicine

Access to resources Recommend Favorite

The 2013 Society of Surgical Oncology Susan G. Komen for the Cure Symposium: MRI in Breast Cancer: Where Are We Now?

By McLaughlin Sarah   Mittendorf Elizabeth   Bleicher Richard   McCready David   King Tari  

Annals of Surgical Oncology, Vol. 21, Iss. 1, 2014-01 ,pp. : 28-36

Springer Publishing Company

Access to resources Recommend Favorite

Stereotactic Body Radiotherapy (SBRT) in the Management of Clinically Localized Prostate Cancer: Where are We Now?

By  

Current Cancer Therapy Reviews, Vol. 14, Iss. 1, 2018-02 ,pp. : 31-45

Bentham Science Publishers

Access to resources Recommend Favorite

Gastroenteropancreatic neuroendocrine tumors. Where are we now?

By Castellano Daniel  

Cancer and Metastasis Reviews, Vol. 30, Iss. 1, 2011-03 ,pp. : 1-1

Springer Publishing Company

Access to resources Recommend Favorite